Who owns the EBANGA trademark?

The EBANGA trademark is owned by Ridgeback Biotherapeutics L.P..

What class is the EBANGA trademark registered in?

The EBANGA trademark is registered in Class 005 (Pharmaceuticals, medical & veterinary preparations).

What is the serial number for EBANGA?

The USPTO serial number for EBANGA is 98599610.

What is the registration number for EBANGA?

EBANGA is registered under USPTO registration number 8224811.

Sealvo

Home Search: EBANGAEBANGA #98599610

Back

Updated Oct 22, 2026·40 searches this week

View on USPTO TSDR Find similar marks

EBA

USPTO Trademark Record

REGISTERED

EBANGA

SN 98599610·Reg 8224811·Filed Jun 13, 2024

Owner Ridgeback Biotherapeutics L.P.

Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary purposes, food for babies; dietary supplements for human beings and animals; adhesive plasters, materials for dressings; material for filling teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.

EBANGA (Serial No. 98599610), Registration No. 8224811, is a registered US trademark filed on Jun 13, 2024 by Ridgeback Biotherapeutics L.P.. This trademark covers Class 005 (Pharmaceuticals, medical & veterinary preparations).

early section 8: April 21, 2032

Mark Intelligence

EBANGA (Reg. #8224811) is a registered US trademark that has been protecting its owner, Ridgeback Biotherapeutics L.P., since 2024. The mark covers Class 005 (Pharmaceuticals, medical & veterinary preparations). Goods and services include Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and subs.... The mark faced 1 opposition proceeding during prosecution.

FILED

Jun 13, 2024

SERIAL

98599610

REG#

8224811

REGISTERED

Apr 21, 2026

Filing Information

StatusREGISTERED

Filing DateJun 13, 2024

Serial Number98599610

Registration No.8224811

Registration DateApr 21, 2026

Status DateApr 21, 2026

Published for OppositionFeb 04, 2025

Filing Basis & Declarations

Standard Characters ClaimedUse Application CurrentlyTrademark

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 005Pharmaceuticals, medical & veterinary preparations

US codes: 005, 006, 018, 044, 046, 051, 052

First use anywhere: Jul 22, 2025

First use in commerce: Jul 22, 2025

This description is as filed with the USPTO and defines the scope of trademark protection.

Run a conflict check

Search by serial number, mark name, or logo. See conflicting marks ranked by risk with clear explanations of what contributed.

Run conflict check

Status History

27 events

REGISTERED-PRINCIPAL REGISTER

Apr 21, 2026

REGISTERED-PRINCIPAL REGISTER

NOTICE OF REGISTRATION CONFIRMATION EMAILED

Apr 21, 2026

NOTICE OF REGISTRATION CONFIRMATION EMAILED

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

Apr 01, 2026

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

Apr 01, 2026

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

ASSIGNED TO LIE

Mar 31, 2026

ASSIGNED TO LIE

CORRESPONDENCE RECEIVED IN LAW OFFICE

Mar 31, 2026

CORRESPONDENCE RECEIVED IN LAW OFFICE

TEAS/EMAIL CORRESPONDENCE ENTERED

Mar 31, 2026

TEAS/EMAIL CORRESPONDENCE ENTERED

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Mar 25, 2026

TEAS RESPONSE TO OFFICE ACTION RECEIVED

SU - NON-FINAL ACTION - WRITTEN

Mar 16, 2026

SU - NON-FINAL ACTION - WRITTEN

NON-FINAL ACTION E-MAILED

Mar 16, 2026

NON-FINAL ACTION E-MAILED

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Mar 16, 2026

NOTIFICATION OF NON-FINAL ACTION E-MAILED

STATEMENT OF USE PROCESSING COMPLETE

Mar 11, 2026

STATEMENT OF USE PROCESSING COMPLETE

CASE ASSIGNED TO INTENT TO USE PARALEGAL

Mar 10, 2026

CASE ASSIGNED TO INTENT TO USE PARALEGAL

TEAS STATEMENT OF USE RECEIVED

Sep 03, 2025

TEAS STATEMENT OF USE RECEIVED

USE AMENDMENT FILED

Sep 03, 2025

USE AMENDMENT FILED

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Apr 01, 2025

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

PUBLISHED FOR OPPOSITION

Feb 04, 2025

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Feb 04, 2025

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Jan 29, 2025

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

EXAMINERS AMENDMENT -WRITTEN

Jan 08, 2025

EXAMINERS AMENDMENT -WRITTEN

EXAMINERS AMENDMENT E-MAILED

Jan 08, 2025

EXAMINERS AMENDMENT E-MAILED

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

Jan 08, 2025

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

EXAMINER'S AMENDMENT ENTERED

Jan 08, 2025

EXAMINER'S AMENDMENT ENTERED

APPROVED FOR PUB - PRINCIPAL REGISTER

Jan 08, 2025

APPROVED FOR PUB - PRINCIPAL REGISTER

ASSIGNED TO EXAMINER

Jan 05, 2025

ASSIGNED TO EXAMINER

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Jan 03, 2025

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

NEW APPLICATION ENTERED

Jun 13, 2024

NEW APPLICATION ENTERED

Other Marks by Ridgeback Biotherapeutics L.P.

Additional USPTO filings from the same owner.

EBA

EBANGA

90178466

RIDGEBACK BIOTHERAPEUTICS L.P.

ABANDONED

ANS

ANSUVIMAB

88921860

RIDGEBACK BIOTHERAPEUTICS L.P.

ABANDONED

EBO

EBOLEX

88708445

RIDGEBACK BIOTHERAPEUTICS L.P.

ABANDONED

EBO

EBOMAX

88708493

RIDGEBACK BIOTHERAPEUTICS L.P.

ABANDONED

Other Marks in Class 005 — Pharmaceuticals, medical & veterinary preparations

Recently filed and registered marks in the same international class.

EBA

EBANGA

90178466

RIDGEBACK BIOTHERAPEUTICS L.P.

ABANDONED

Other Marks by Eric J. Shimanoff

Additional USPTO filings handled by the same attorney of record.

SIG

SIGNALBRIDGE

99163213

REGISTERED

HAR

HARTFORD INNOVATION WEEK

99788834

REGISTERED

99175586

REGISTERED

IAT

IATSE

90092734

REGISTERED

EBANGA

Run a conflict check

Other Marks by Ridgeback Biotherapeutics L.P.

Other Marks in Class 005 — Pharmaceuticals, medical & veterinary preparations

Other Marks by Eric J. Shimanoff

Get pre-filing clearance

Search 14M+ trademarks

Resources

Company